Schrodinger Companies

Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas.


Invests into

Headquarters: New York
Founded Date: 1990
Estimated Revenue: $35.29M
Investor Type: Venture Capital Funds
Employee Number: 501-1000